BiotechTube
Home/Exosla Therapeutics/Daniel Gau
DG

Daniel Gau

Development Lead

Exosla Therapeutics

Therapeutic Areas

NeurologyNeonatology

Exosla Therapeutics Pipeline

DrugIndicationPhase
EV-based Neurorestorative TherapyNeurological injury in newborn infantsPre-clinical

Leadership Team at Exosla Therapeutics

GW
Gareth Willis
Founder and CEO
BG
Bernd Giebel
Founder and CSO
PA
Pierre Arsène
Founder and Executive Chair
View full Exosla Therapeutics profile